Zivo BioscienceZIVO +42.86%14 Gross Margin % is 31.82% as of Sep. 2025, which is 14% below its 10-year median of 37.04. GuruFocus rates ZIVO with a GF Score™ of 14/100. The stock has 5 warning signs investors should review. Among 735 Biotechnology companies, Zivo Bioscience ranks worse than 75.24% on this metric.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Zivo Bioscience had a gross margin of 31.82% for the quarter that ended in Sep. 2025 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Zivo Bioscience Gross Margin % Related Terms
Zivo Bioscience Gross Margin % Historical Data
* Premium members only.
The historical data trend for Zivo Bioscience's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ZIVO vs ATOS, QNCX, AEON: Gross Margin % Comparison
For the Biotechnology subindustry, Zivo Bioscience's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zivo Bioscience Gross Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Zivo Bioscience's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Zivo Bioscience's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Zivo Bioscience (ZIVO) has a Gross Margin % of 31.82% as of Sep. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Zivo Bioscience and its competitors. This is 14% below median its historical median of 37.04. Over the past decade, Zivo Bioscience's Gross Margin % has ranged from 31.21 to 42.86. According to the industry distribution chart, Zivo Bioscience ranks #553 out of 735 companies in the Biotechnology industry, placing it in the top 75.2%.
Is Zivo Bioscience's Gross Margin % too high?
Zivo Bioscience's current Gross Margin % of 31.82% is 14% below median its 10-year median of 37.04. Over the past 10 years, this metric has ranged from a low of 31.21 to a high of 42.86. The Biotechnology industry median Gross Margin % is 60.90. Zivo Bioscience's value of 31.82% is 47.8% below this industry median. Based on the distribution chart, Zivo Bioscience ranks #553 out of 735 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Zivo Bioscience has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does Zivo Bioscience's Gross Margin % compare to ATOS and QNCX?
According to the Biotechnology industry distribution chart, Zivo Bioscience ranks #553 out of 735 companies for Gross Margin %. This places Zivo Bioscience in the lower half of its industry. The industry median Gross Margin % is 60.90. Zivo Bioscience's value of 31.82% is 47.8% below this benchmark. Historically, Zivo Bioscience's own Gross Margin % has ranged from 31.21 to 42.86 over the past decade. While the company's 10-year median is 37.04 vs. the industry median of 60.90, Zivo Bioscience has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Biotechnology company?
The median Gross Margin % among Biotechnology companies is 60.90, based on 735 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zivo Bioscience's current Gross Margin % of 31.82% is 47.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Zivo Bioscience and its competitors. For the Biotechnology industry, the median Gross Margin % is 60.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zivo Bioscience's current Gross Margin % is 31.82%, which is 14% below median its own 10-year median of 37.04. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zivo Bioscience stock overvalued right now?
Zivo Bioscience (ZIVO) has a current Gross Margin % of 31.82%. The current Gross Margin % is 31.82%, which is 14% below median its 10-year median of 37.04 and 47.8% below the Biotechnology industry median of 60.90. Zivo Bioscience's overall GF Score™ is 14/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Zivo Bioscience (ZIVO), the current Gross Margin % is 31.82% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zivo Bioscience Inc operates in one reportable segment microalgae technology. The segment is research and development operating in both the therapeutic and nutritional sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. The company's applications are ANIMAL APPLICATIONS, HUMAN APPLICATIONS.
14GF Score
Get the complete analysis for ZIVO
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ZIVO has been successfully added to your 
